Hubei Guangji Pharmaceutical Co. Ltd. | Ownership
Companies that own Hubei Guangji Pharmaceutical Co. Ltd.
Huashang Fund Management Co., Ltd.
4,381,848
1.74%
4,381,848
0.28%
12/31/2016
China Asset Management Co., Ltd.
3,600,000
1.43%
969,447
0.03%
12/31/2016
AXA-SPDB Investment Managers Co., Ltd.
2,499,866
0.99%
2,499,866
0.46%
12/31/2016
GF Fund Management Co., Ltd.
152,600
0.06%
13,900
0%
12/31/2017
UBS SDIC Fund Management Co., Ltd.
103,200
0.04%
-28,800
0.01%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
8,500
0%
8,500
0%
12/31/2017
China Southern Asset Management Co., Ltd.
5,600
0%
-55,200
0%
12/31/2017
Lion Fund Management Co., Ltd.
5,501
0%
5,501
0%
12/31/2017
Wanjia Asset Management Co., Ltd.
4,800
0%
-700
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
4,000
0%
-700
0%
12/31/2017
| Address |
No. 1 Jiangdi Road
Wuxue Hubei 435400
China
|
|
Employees
|
- |
| Website |
http://www.guangjipharm.com |
| Updated |
07/08/2019 |
| Hubei Guangji Pharmaceutical Co., Ltd. engages in the manufacture and sale pharmaceutical raw materials, and fine chemicals and preparation. It offers products in the form of granules, tablets, injections, ointments, and gels. Its products also include riboflavin vitamin B2 feed and pharmaceutical grade, lafutidine tablets, and tinidazole injections. |
